IFNGR1 and neoplasm: In contrast, in solid tumors, loss of IFN-γR signaling pathway reduces the killing efficacy of CAR T-cells by increasing the resistance of tumor cells to CAR-T, mediating the development of CAR T-cell resistance in solid tumors.